Health
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial – DocWire News
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly…
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly improve symptoms and quality of life in adults with heart failure, whether or not they also had type 2 diabetes. Findings from…
Continue Reading
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General24 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News22 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz